[1]Patent:US2006/122189,2006,A1,.Locationinpatent:Page/Pagecolumn20
[1]Patent:WO2009/153307,2009,A1,.Locationinpatent:Page/Pagecolumn38
[2]Patent:US2010/29729,2010,A1,.Locationinpatent:Page/Pagecolumn18
[1]OrganicLetters,2006,vol.8,#10,p.1975-1978
[2]BioorganicandMedicinalChemistry,2010,vol.18,#2,p.557-566
[1]OrganicandBiomolecularChemistry,2017,vol.15,#20,p.4291-4294
[1]Patent:WO2005/66132,2005,A1.Locationinpatent:Page/Pagecolumn67
[2]JournalofMedicinalChemistry,1983,vol.26,p.294-298
[3]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.81-86
[4]Patent:WO2009/153307,2009,A1.Locationinpatent:Page/Pagecolumn38-39
[5]Patent:US2010/29729,2010,A1.Locationinpatent:Page/Pagecolumn18
[6]Patent:US2014/275070,2014,A1.Locationinpatent:Paragraph0234
[1]OrganicLetters,2006,vol.8,p.1975-1978
[2]Patent:US3976639,1976,A
[3]Patent:US2003/73849,2003,A1
[1]JournalofMedicinalChemistry,1997,vol.40,p.2843-2857
[2]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.81-86
[1]CurrentPatentAssignee:ELILILLY&CO-US2003/225092,2003,A1Locationinpatent:Page17
[1]ChemicalCommunications,2012,vol.48,p.5187-5189
Title: 6-(1H-Tetra-zol-5-yl)-1H-indole monohydrate.
Journal: Acta crystallographica. Section E, Structure reports online 20110301